ライフサイエンスコーパス: coronary artery bypass

1 ate analysis identified donor age >40 years, coronary artery bypass, and no aspirin after LT as indep

2 Cardiac surgery, including coronary artery bypass, cardiac valve, and aortic proced

3 on (20.6% versus 11.5%, P=0.03) and previous coronary artery bypass graft (22.1% versus 11.0%, P=0.01

4 I (24.3% versus 28.3%, P=0.001), or previous coronary artery bypass graft (4.6% versus 7.2%, P<0.001)

5 In the APTITUDE-Coronary Artery Bypass Graft (APTITUDE-CABG) study, vaso

6 ercutaneous coronary intervention (PCI), and coronary artery bypass graft (CABG) are an unintended co

7 coronary artery disease (LMCAD) treated with coronary artery bypass graft (CABG) or percutaneous coro

8 cutaneous coronary intervention (PCI) versus coronary artery bypass graft (CABG) routinely exclude pa

9 For patients without CKD, coronary artery bypass graft (CABG) surgery combined wit

10 e (CAD) had improved long-term outcomes with coronary artery bypass graft (CABG) surgery compared wit

11 orary drug-eluting stent (DES) compared with coronary artery bypass graft (CABG) surgery in patients

12 Coronary artery bypass graft (CABG) surgery is the gold-

13 his study is to compare HCR and conventional coronary artery bypass graft (CABG) surgery medium-term

14 ts aged 60 years or older undergoing on-pump coronary artery bypass graft (CABG) surgery or combined

15 ss of coronary revascularization with either coronary artery bypass graft (CABG) surgery or percutane

16 gnosis and a greater prognostic benefit from coronary artery bypass graft (CABG) surgery than those w

17 d improve patients' prognosis after elective coronary artery bypass graft (CABG) surgery.

18 Data are sparse on long-term mortality after coronary artery bypass graft (CABG) surgery.

19 percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) surgery.

20 tal knee or hip arthroplasty; spine surgery; coronary artery bypass graft (CABG) surgery; and craniot

21 Multiple studies have compared coronary artery bypass graft (CABG) with percutaneous co

22 ies: abdominal aortic aneurysm repair (AAA), coronary artery bypass graft (CABG), colectomy, or hip r

23 Individuals who underwent colon resection, coronary artery bypass graft (CABG), lung resection, or

24 atients who underwent colectomy/proctectomy, coronary artery bypass graft (CABG), pancreaticoduodenec

25 with low risk of immediate complications, or coronary artery bypass graft (CABG), with improved long-

26 nce intervals, 1.02-1.03; P<0.001), previous coronary artery bypass graft (OR, 1.44; 95% confidence i

27 rcutaneous Coronary Intervention - PCI - and Coronary Artery Bypass Graft - CABG) among groups of pop

28 ive, high-risk cardiac surgery (ie, combined coronary artery bypass graft [CABG] surgery and valve re

29 elines recommend surgical revascularization (coronary artery bypass graft [CABG]) over percutaneous c

30 theterization followed by treatment (ie, 128 coronary artery bypass graft [CABG], 150 percutaneous co

31 There also were >18,000 fewer coronary artery bypass graft admissions in 2012 than in

32 dergone cardiothoracic intervention, such as coronary artery bypass graft and valve replacement surge

33 ariable cost in patients undergoing elective coronary artery bypass graft and valve surgeries.

34 ive RASi and outcomes in patients undergoing coronary artery bypass graft and/or valve surgery.

35 7% men) were included, with a mean time from coronary artery bypass graft of 12+/-5 years.

36 an skeletal muscle biopsies from a cohort of coronary artery bypass graft patients treated with eithe

37 missions Database for patients who underwent coronary artery bypass graft repair with and without LAA

38 Hospitals that performed 1 or more coronary artery bypass graft surgeries in a given calend

39 ence of diabetes mellitus (45%) and previous coronary artery bypass graft surgery (34%).

40 er medical therapy alone (63% versus 21%) or coronary artery bypass graft surgery (81% versus 7%).

41 s (SVGs) occlude during the first year after coronary artery bypass graft surgery (CABG) despite aspi

42 h (SCD) in patients with heart failure after coronary artery bypass graft surgery (CABG) has not been

43 New-onset atrial fibrillation (AF) after coronary artery bypass graft surgery (CABG) is associate

44 Guidelines recommend coronary artery bypass graft surgery (CABG) over percuta

45 total of 60 patients with CAD indicated for coronary artery bypass graft surgery (CABG) were include

46 oronary interventions in patients with prior coronary artery bypass graft surgery (CABG).

47 determinants of long-term outcome following coronary artery bypass graft surgery (CABG).

48 , 0.61; 95% confidence interval, 0.55-0.67), coronary artery bypass graft surgery (n=1077; hazard rat

49 ast lumpectomy [18 018]; colectomy [14 074]; coronary artery bypass graft surgery [6378]) by an in-ne

50 However, there is paucity of data comparing coronary artery bypass graft surgery against newer gener

51 nd CSCs were isolated from vein leftovers of coronary artery bypass graft surgery and discarded atria

52 (with percutaneous coronary intervention or coronary artery bypass graft surgery as appropriate) plu

53 ,402 multivessel disease patients undergoing coronary artery bypass graft surgery between January 1,

54 l infarction/cardiogenic shock (n=1705), and coronary artery bypass graft surgery groups.

55 LAA exclusion during isolated coronary artery bypass graft surgery in patients with at

56 without acute coronary syndromes or previous coronary artery bypass graft surgery in periods before (

57 had diabetes mellitus and underwent isolated coronary artery bypass graft surgery or percutaneous cor

58 ischemic stroke, and revascularization with coronary artery bypass graft surgery or percutaneous cor

59 ntly more complex, both clinically (previous coronary artery bypass graft surgery prevalence, 48% ver

60 artery (RA) can improve clinical outcomes in coronary artery bypass graft surgery remains unclear.

61 nts with no acute coronary syndrome/no prior coronary artery bypass graft surgery that were rated as

62 iabetes [ejection fraction >50%]) undergoing coronary artery bypass graft surgery was obtained by sub

63 aneous coronary intervention [PCI], PCI, and coronary artery bypass graft surgery).

64 tal, we analyzed 253 287 patients undergoing coronary artery bypass graft surgery, 7.0% of whom recei

65 aring percutaneous coronary intervention and coronary artery bypass graft surgery, and differences in

66 uitable collaterals, no smoking, no previous coronary artery bypass graft surgery, and left anterior

67 Death, myocardial infarction, coronary artery bypass graft surgery, and repeat PCI wer

68 harvesting (EVH) should be standard care in coronary artery bypass graft surgery, but vein quality a

69 al Health Insurance Database associated with coronary artery bypass graft surgery, myocardial infarct

70 ut lower rates of multivessel disease, prior coronary artery bypass graft surgery, prior MI, and smok

71 spital percutaneous coronary intervention or coronary artery bypass graft surgery, respectively.

72 Patients underwent either isolated coronary artery bypass graft surgery, single noncoronary

73 death, angiogram-confirmed angina pectoris, coronary artery bypass graft surgery, stents, and angiop

74 myocardial infarction, coronary angioplasty, coronary artery bypass graft surgery, stroke).

75 who underwent cardiac interventions, such as coronary artery bypass graft surgery, were also included

76 onary intervention, or previous multi-vessel coronary artery bypass graft surgery.

77 Is; and 19 (1.6%) more sites were performing coronary artery bypass graft surgery.

78 ison with IV propofol for patient undergoing coronary artery bypass graft surgery.

79 onsortium (BARC) major bleeding unrelated to coronary artery bypass graft surgery.

80 risk of death and stroke when compared with coronary artery bypass graft surgery.

81 with atrial fibrillation undergoing isolated coronary artery bypass graft surgery.

82 patients with multivessel disease undergoing coronary artery bypass graft surgery.

83 ervention to either medical therapy alone or coronary artery bypass graft surgery.

84 phically confirmed angina (1.91; 1.59-2.29), coronary artery bypass graft surgery/coronary angioplast

85 mained at higher risk for repeat procedures (coronary artery bypass graft surgery: 10.7% versus 6.8%,

86 for target vessel or target lesion failure (coronary artery bypass graft surgery: 8.9% versus 3.9%,

87 ive atrial fibrillation within 30 days after coronary artery bypass graft was 2 of 30 patients (7%) i

88 acute coronary syndromes patients with prior coronary artery bypass graft were prospectively screened

89 Procedures other than coronary artery bypass graft were valve surgery, surgery

90 trial that enrolled patients with a previous coronary artery bypass graft who had developed at least

91 death resulting from CVD, heart failure, or coronary artery bypass graft) over a 26-year median foll

92 ation (percutaneous coronary intervention or coronary artery bypass graft) was performed during index

93 farction, unstable and stable angina, recent coronary artery bypass graft, and peripheral arterial di

94 resection, abdominal aortic aneurysm repair, coronary artery bypass graft, aortic valve replacement,

95 1 patients aged 60 years or older undergoing coronary artery bypass graft, aortic valve surgery, mitr

96 underwent abdominal aortic aneurysm repair, coronary artery bypass graft, or colon resection for neo

97 ADBRs included non-coronary artery bypass graft-related Thrombolysis In Myo

98 tes of PCI failure or complication requiring coronary artery bypass grafting (0.67 [0.56-0.79], P<0.0

99 lectomy (189229 patients at 1876 hospitals), coronary artery bypass grafting (CABG) (218940 patients

100 after the procedure between on- and off-pump coronary artery bypass grafting (CABG) (n = 6; low SOE),

101 ending within 90-days of discharge following coronary artery bypass grafting (CABG) and aortic valve

102 n with percutaneous coronary intervention or coronary artery bypass grafting (CABG) and its long-term

103 acute coronary syndrome (ACS) and history of coronary artery bypass grafting (CABG) are at high risk

104 re, and coronary artery disease suitable for coronary artery bypass grafting (CABG) are at higher ris

105 Percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) are considered re

106 ved ejection fraction in patients undergoing coronary artery bypass grafting (CABG) are limited and i

107 The long-term outcomes of off-pump coronary artery bypass grafting (CABG) are the subject o

108 omly assigned to undergo off-pump or on-pump coronary artery bypass grafting (CABG) at 12 centers in

109 nd MV replacement and repair with or without coronary artery bypass grafting (CABG) between 2007 and

110 tality by race group for patients undergoing coronary artery bypass grafting (CABG) between 2011 and

111 coronary syndromes (ACS) undergoing isolated coronary artery bypass grafting (CABG) compared with asp

112 telet therapy (DAPT) in patients who undergo coronary artery bypass grafting (CABG) following acute c

113 taneous coronary intervention (PCI) group or coronary artery bypass grafting (CABG) group.

114 h left main coronary artery (LMCA) stenosis, coronary artery bypass grafting (CABG) has been the stan

115 ts with multivessel coronary artery disease, coronary artery bypass grafting (CABG) has shown long-te

116 ercutaneous coronary intervention (PCI) with coronary artery bypass grafting (CABG) in patients with

117 st-generation paclitaxel-eluting stents with coronary artery bypass grafting (CABG) in patients with

118 mited data regarding long-term results after coronary artery bypass grafting (CABG) in young adults.

119 (DM) and multivessel coronary disease (MVD), coronary artery bypass grafting (CABG) is superior to pe

120 Coronary artery bypass grafting (CABG) is the standard t

121 percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) is unknown.

122 Patients undergoing coronary artery bypass grafting (CABG) must often see mu

123 unclear whether revascularization by either coronary artery bypass grafting (CABG) or percutaneous c

124 It is unknown if coronary artery bypass grafting (CABG) or percutaneous c

125 d data on outcomes of patients with previous coronary artery bypass grafting (CABG) presenting with S

126 Background Over 180 000 coronary artery bypass grafting (CABG) procedures are pe

127 icated in stroke risk at the time of on-pump coronary artery bypass grafting (CABG) procedures.

128 Coronary artery bypass grafting (CABG) remains the stand

129 Current guidelines suggest that coronary artery bypass grafting (CABG) should be the pre

130 arization and reduced survival with off-pump coronary artery bypass grafting (CABG) surgery compared

131 cutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) surgery in the EX

132 omized trial data support the superiority of coronary artery bypass grafting (CABG) surgery over perc

133 coronary artery disease (CAD), who underwent coronary artery bypass grafting (CABG) surgery.

134 isease) trial demonstrated that, on average, coronary artery bypass grafting (CABG) was superior to p

135 th from randomized trials that have compared coronary artery bypass grafting (CABG) with percutaneous

136 the current outcomes of patients undergoing coronary artery bypass grafting (CABG) with prior surgic

137 regate costs: 30% in Colectomy (COL), 22% in coronary artery bypass grafting (CABG), 19% in Total Hip

138 nal aortic aneurysm (AAA) repair, colectomy, coronary artery bypass grafting (CABG), hip or knee repl

139 percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG), on long-term out

140 cular (LV) biopsies from patients undergoing coronary artery bypass grafting (CABG), only the activat

141 disease in place of the standard treatment, coronary artery bypass grafting (CABG).

142 percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG).

143 nary ischemia is an uncommon complication of coronary artery bypass grafting (CABG).

144 nd with a higher risk of complications after coronary artery bypass grafting (CABG).

145 an increased risk of adverse outcomes after coronary artery bypass grafting (CABG).

146 predict cardiovascular events or death after coronary artery bypass grafting (CABG).

147 ion (PCI), while those in the SAVR group had coronary artery bypass grafting (CABG).

148 cutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG).

149 inically significant bleeding not related to coronary artery bypass grafting (CABG; major, minor, or

150 CABG from the European Multicenter Study on Coronary Artery Bypass Grafting (E-CABG) registry betwee

151 0.64; 95% confidence interval, 0.60-0.69) or coronary artery bypass grafting (hazard ratio, 0.53; 95%

152 tio, 0.68 [95% CI, 0.59-0.79]; P<0.0001) and coronary artery bypass grafting (hazard ratio, 0.61 [95%

153 ment (HFpEF(AVR), n=5; and HFrEF(AVR), n=4), coronary artery bypass grafting (HFpEF(CABG), n=5; and H

154 -main disease who underwent primary isolated coronary artery bypass grafting (MAG, n = 5580; LITA+SVG

155 ty of Thoracic Surgeons composite rating for coronary artery bypass grafting (STS-CABG), and Centers

156 y (1.85; 95% CI, 1.33-2.58) and lowest after coronary artery bypass grafting + mitral valve surgery (

157 ith CAD requiring surgical intervention (CAD-coronary artery bypass grafting [CABG]) and those who di

158 (percutaneous coronary intervention [PCI] or coronary artery bypass grafting [CABG]) or optimal medic

159 on adjusted OR: 0.74; 95% CI: 0.73 to 0.75) (coronary artery bypass grafting adjusted OR: 0.61; 95% C

160 no clear guidelines on the use of the RA in coronary artery bypass grafting after its catheterizatio

161 s showed that a higher number of years since coronary artery bypass grafting and >1 target saphenous

162 cribes 20-year results of RA grafts used for coronary artery bypass grafting and the effects of RA re

163 Of 10 633 adults who underwent coronary artery bypass grafting and valve surgery betwee

164 Patients having coronary artery bypass grafting and/or cardiac valve rep

165 Patients with pAF after coronary artery bypass grafting are at higher risk of CV

166 s should be maximized in patients undergoing coronary artery bypass grafting because they have excell

167 oderate and 174 (1.87%) TIMI major/minor non-coronary artery bypass grafting bleeding events occurred

168 ld have on previously cannulated RAs used as coronary artery bypass grafting conduits.

169 A total of 508 patients who underwent coronary artery bypass grafting for cardiogenic shock co

170 ly enrolled 113 patients undergoing elective coronary artery bypass grafting for cross-sectional stud

171 ternal mammary artery (BIMA) conduits during coronary artery bypass grafting have better long-term su

172 Nearly 50% of patients undergoing coronary artery bypass grafting have diabetes.

173 ring treatment that has been shown to reduce coronary artery bypass grafting in a blinded, randomized

174 alysis of the GOPCABE trial (German Off-Pump Coronary Artery Bypass Grafting in Elderly Patients) rev

175 ns about competitive flow and the benefit of coronary artery bypass grafting in intermediate LAD sten

176 ial infarction is an indication for emergent coronary artery bypass grafting in patients not amenable

177 antly higher risk of mortality and emergency coronary artery bypass grafting in patients treated by n

178 Emergency coronary artery bypass grafting in patients with acute m

179 ader spectrum of patients who are undergoing coronary artery bypass grafting in routine practice.

180 ary surgical AVR with or without concomitant coronary artery bypass grafting in Sweden between 1995 a

181 Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unpr

182 ostoperative atrial fibrillation (pAF) after coronary artery bypass grafting is a common complication

183 Coronary artery bypass grafting is among the most common

184 of a third arterial conduit in patients with coronary artery bypass grafting is not associated with h

185 n (HCR) combines minimally invasive surgical coronary artery bypass grafting of the left anterior des

186 ied, having a primary diagnosis of emergency coronary artery bypass grafting or valve replacement, an

187 as built upon a hierarchical segmentation of coronary artery bypass grafting procedures and a cued-re

188 esses related to the intraoperative phase of coronary artery bypass grafting procedures.

189 issions Reduction Program formula using only coronary artery bypass grafting readmissions with a 3% m

190 Coronary artery bypass grafting remains one of the most

191 conduit improves outcomes after multivessel coronary artery bypass grafting remains unclear.

192 retrospective analysis of 47 984 consecutive coronary artery bypass grafting surgeries performed from

193 Among the study population, 1482 coronary artery bypass grafting surgeries with BIMA were

194 nnaire (SAQ) and angiographic findings after coronary artery bypass grafting surgery (CABG) are lacki

195 cutaneous coronary intervention (PCI) versus coronary artery bypass grafting surgery (CABG) on mortal

196 us Vein Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting Surgery) investigated wh

197 two to three times more likely to die after coronary artery bypass grafting surgery.

198 We randomly assigned 304 patients undergoing coronary artery bypass grafting using BITA to either in

199 ween percutaneous coronary interventions and coronary artery bypass grafting using either coronary co

200 A treatment recommendation of coronary artery bypass grafting was made in 24% of the p

201 Coronary artery bypass grafting was performed in a 4-yea

202 , patient-level mortality rates for isolated coronary artery bypass grafting were consistently lower

203 ndomized clinical trial, patients undergoing coronary artery bypass grafting with an internal mammary

204 th low ejection fraction who were undergoing coronary artery bypass grafting with cardiopulmonary byp

205 o 40% and scheduled for isolated or combined coronary artery bypass grafting with cardiopulmonary byp

206 who underwent primary, isolated multivessel coronary artery bypass grafting with the left internal t

207 studies comparing the long-term outcomes of coronary artery bypass grafting with the use of 2-arteri

208 tus by percutaneous coronary intervention or coronary artery bypass grafting within 7 days of the ind

209 with multivessel disease who are undergoing coronary artery bypass grafting without increased mortal

210 eficiaries who underwent elective colectomy, coronary artery bypass grafting, abdominal aortic aneury

211 primary percutaneous coronary intervention, coronary artery bypass grafting, and medical therapy, re

212 l artery (RA) is a commonly used conduit for coronary artery bypass grafting, and recent studies have

213 jury in percutaneous coronary interventions, coronary artery bypass grafting, and reperfused acute my

214 ubgroup analysis of patients undergoing only coronary artery bypass grafting, and results were simila

215 impact on the function of RA grafts used in coronary artery bypass grafting, and there is now compre

216 cohort study included patients who underwent coronary artery bypass grafting, and/or aortic, mitral o

217 spanic, and Asian Medicare beneficiaries for coronary artery bypass grafting, colectomy, total hip ar

218 er 30, 2018: total knee or hip arthroplasty, coronary artery bypass grafting, colectomy, ventral hern

219 lve replacement and aortic valve replacement+coronary artery bypass grafting, extensive updating usin

220 ve criteria: a history of previous PCI or of coronary artery bypass grafting, or documentation of ang

221 nditions, and in-hospital procedures such as coronary artery bypass grafting, percutaneous coronary i

222 oviding a treatment recommendation, that is, coronary artery bypass grafting, percutaneous coronary i

223 We identified patients who underwent coronary artery bypass grafting, pulmonary lobectomy, en

224 Following coronary artery bypass grafting, there is a massive incr

225 f 283,131 patients who were readmitted after coronary artery bypass grafting, to 142,142 (83.2%) of 1

226 Secondary end points included emergency coronary artery bypass grafting, vascular complications,

227 utaneous coronary intervention, or equipoise coronary artery bypass grafting-percutaneous coronary in

228 their performance to predict adjudicated non-coronary artery bypass grafting-related GUSTO (Global Us

229 efits in the majority of patients undergoing coronary artery bypass grafting.

230 should be considered more frequently during coronary artery bypass grafting.

231 ary intervention, and 2832 (10.7%) underwent coronary artery bypass grafting.

232 , 57,961 patients underwent primary isolated coronary artery bypass grafting.

233 of 2 arterial grafts in patients undergoing coronary artery bypass grafting.

234 this contributes to clinical outcomes after coronary artery bypass grafting.

235 ions, contemporary practice, and outcomes of coronary artery bypass grafting.

236 improve short- and long-term outcomes after coronary artery bypass grafting.

237 ion, percutaneous coronary intervention, and coronary artery bypass grafting.

238 and improved survival in patients undergoing coronary artery bypass grafting.

239 eous coronary intervention and >10 times for coronary artery bypass grafting.

240 scending (LAD) artery in patients undergoing coronary artery bypass grafting.

241 m were obtained from 306 patients undergoing coronary artery bypass grafting.

242 rone that was similar to patients undergoing coronary artery bypass grafting.

243 .0% of patients and were most frequent after coronary artery bypass grafting.

244 vein (LSV) is commonly used as a conduit in coronary artery bypass grafting.

245 betes, prior myocardial infarction, PCI, and coronary artery bypass grafting.

246 y rates than saphenous vein grafts (SVGs) in coronary artery bypass grafting.

247 ial infarction, stroke, tamponade, or urgent coronary artery bypass grafting.

248 rcutaneous coronary intervention: 28 011 and coronary artery bypass grafting: 6277).

249 ade: r=0.46; P=0.0001) and SAVR (concomitant coronary artery bypass grafting: r=-0.33; P=0.03).

250 The survival benefit of a strategy of coronary-artery bypass grafting (CABG) added to guidelin

251 In a trial comparing coronary-artery bypass grafting (CABG) alone with CABG p

252 coronary artery disease that was amenable to coronary-artery bypass grafting (CABG) and who had a lef

253 ral internal thoracic (mammary) arteries for coronary-artery bypass grafting (CABG) may improve long-

254 Coronary-artery bypass grafting (CABG) surgery may be pe

255 r survival than single arterial grafts after coronary-artery bypass grafting (CABG) surgery.

256 porary drug-eluting stents, as compared with coronary-artery bypass grafting (CABG), in patients with

257 nary artery disease are usually treated with coronary-artery bypass grafting (CABG).

258 us-vein graft is the most common conduit for coronary-artery bypass grafting (CABG).

259 ronary chronic total occlusions (CTOs) after coronary artery bypass grafts (CABGs) is higher than in

260 acute coronary syndromes patients with prior coronary artery bypass grafts appears warranted.

261 e invasive management in patients with prior coronary artery bypass grafts presenting with non-ST ele

262 cardiac surgery, especially the presence of coronary artery bypass grafts, is thought to preclude pe

263 nts with previous cardiac surgery, including coronary artery bypass grafts.

264 utaneous coronary intervention (28%), urgent coronary artery bypass surgery (27.5%), maternal mortali

265 rovide recommendations for optimal timing of coronary artery bypass surgery (CABG) in patients with n

266 s coronary intervention (PCI) With Taxus and coronary artery bypass surgery (CABG)] score is a decisi

267 ry revascularization (HCR) combines arterial coronary artery bypass surgery (most commonly minimally

268 y intervention in patients with a history of coronary artery bypass surgery (PCI-CABG) is limited and

269 Both coronary artery bypass surgery and percutaneous interven

270 lacks and 136,362 whites undergoing isolated coronary artery bypass surgery at 663 Society of Thoraci

271 X]; NCT00114972; Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left

272 2007) and EXCEL (Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left

273 andomized EXCEL (Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left

274 andomized EXCEL (Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left

275 The EXCEL (Evaluation of Xience Versus Coronary Artery Bypass Surgery for Effectiveness of Left

276 hes), and EXCEL (Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left

277 ry in the EXCEL (Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left

278 e SYNTAX scores.(Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left

279 The EXCEL trial (Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left

280 (TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narr

281 high SYNTAX (TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narr

282 the SYNTAX (TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narr

283 YNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narr

284 YNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narr

285 have reported that black patients undergoing coronary artery bypass surgery had worse outcomes than w

286 te and high likelihood of complications, and coronary artery bypass surgery is often required.

287 rhythm was performed in 185 patients during coronary artery bypass surgery of whom 13 had a history

288 dial infarction without procedure] to 55.3% [coronary artery bypass surgery only]).

289 Coronary artery bypass surgery was performed in 44 cases

290 of procedural mortality and morbidity after coronary artery bypass surgery were higher among black p

291 Patients without AF undergoing coronary artery bypass surgery were recruited.

292 Relative to whites, blacks undergoing coronary artery bypass surgery were younger, yet had hig

293 After excluding patients with prior coronary artery bypass surgery, 925 patients were includ

294 the readmitted patients, 13% had PCI, 2% had coronary artery bypass surgery, and 3% died during the r

295 se of previously cannulated RAs as grafts in coronary artery bypass surgery, and there are no clear g

296 We included eligible PCI, coronary artery bypass surgery, and valve surgery patien

297 n cardiac rehabilitation referral after PCI, coronary artery bypass surgery, and valve surgery.

298 eripheral vascular disease, absence of prior coronary artery bypass surgery, angina, low body mass in

299 ng percutaneous coronary intervention (PCI), coronary artery bypass surgery, or valve surgery be refe

300 acute myocardial infarction hospitalization; coronary artery bypass surgery; heart valve repair/repla